ResveratrolvsVitamin K

Resveratrol activates SIRT1 (sirtuin 1), a NAD+-dependent deacetylase that deacetylates histones and non-histone targets including p53, FOXO transcription factors, and NF-κB, regulating cellular stress response, DNA repair, autophagy, and inflammatory pathways in keratinocytes and fibroblasts. It scavenges superoxide anion, hydroxyl radical, and metal-induced free radicals through its phenolic hydroxyl groups. Resveratrol inhibits NF-κB nuclear translocation and downstream cytokine production (TNF-α, IL-1β, IL-6), reducing UV-induced inflammation. It inhibits tyrosinase (mild brightening), matrix metalloproteinase-9 (MMP-9, gelatinase B) to prevent collagen and elastin breakdown, and AP-1 (c-Fos/c-Jun) to reduce photoaging-related gene expression. It may also activate Nrf2, upregulating antioxidant enzymes (HO-1, NQO1). Topical application achieves higher skin tissue concentrations than oral supplementation due to first-pass metabolism. Stability is improved in anhydrous or encapsulated formulations.

Vitamin K (phytonadione/K1) is cofactor for gamma-glutamyl carboxylase, which carboxylates glutamic acid residues in clotting factors II, VII, IX, X and proteins S, C — essential for calcium binding and coagulation cascade activation. Topically promotes reabsorption of subcutaneous extravasated blood by activating local clotting cascades that convert leaked hemoglobin to biliverdin and bilirubin for clearance. Strengthens capillary walls, reduces vascular permeability. For vascular dark circles: improves vessel wall integrity, reduces hemosiderin deposition. Supports elastic fiber production through matrix Gla protein carboxylation. Has anti-inflammatory effects. Clinical use: bruising, post-procedure ecchymosis, periorbital vascular hyperpigmentation. Results require 4-8 weeks consistent application.